Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis.
- 2019-06
- Clinical Trial
- Nutrition 62
- Haina Wang
- L. Mei
- Ying Deng
- Yinhui Liu
- Xiaoqing Wei
- Man Liu
- J. Zhou
- Hong-Peng Ma
- P. Zheng
- Jieli Yuan
- Ming Li
- PubMed: 30852460
- DOI: 10.1016/j.nut.2018.11.018
- Low evidence
- Animal Study
Previously we isolated a Lactobacillus strain named DM9218 that could reduce the serum uric acid (UA) level by assimilating purine nucleosides.
- Effect
- Beneficial
- Effect size
- Large